Prevalence of Hepatitis B and Its Associated Factors Among Pregnant Women in Mogadishu, Somalia
DOI:
https://doi.org/10.14738/abr.511.3876Abstract
Background: Hepatitis B is a major global health problem caused by viral infection that attacks the liver and can cause both acute and chronic disease. There are about 65 million individuals who carry HBV in Africa, with a 25% mortality risk. In sub-Saharan Africa, the prevalence of HBV infection ranges from 9-20%. Pregnant mothers who test positive for both hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) have 70–90% risk of transmitting infection to their newborn infants and about 10–40% risk if they test positive for only HBsAg. Therefore, pregnant women should be routinely screened for HBsAg and hepatitis B vaccine administered at birth to the infants whose mothers test positive. Objective: To identify prevalence of Hepatitis B (HBsAg) and its associated factors among pregnant women in Mogadishu, Somalia. Methodology: This was a hospital based cross-sectional study. This design was used to identify potential risk factors associated with development of Hepatitis B virus. Cross-sectional was used to assess the frequency and distribution of Hepatitis B among pregnant women and to investigate factors associated with it. The study instruments were structured questionnaires which were both categorical and open ended. Data was entered and analyzed with SPSS version 16.0. Both Univariate and Bivariate analysis were carried out to see frequencies and significant associations, a P-value less than 0.05 was considered as significant association. Result: The mean age of the respondents was 24.65 (±6.05) years. It was found that women in the age category of (³30) were more likely to get Hepatitis B compared to those below categories (OR 1.69, 95%CI 1.11-1.89). The study revealed that 96.4% of the respondents were unemployed whose majority (79.1%) were from families of low economic status and these were 2.1 times more likely to contract Hepatitis B compared to the pregnant women who are in the category of middle and high economic status (OR 2.1 95% CI 1.25-3.21). The study reported that mothers with gravidity of 7 and more were 2.1 times (OR 2.1, 95%CI 1.31-3.04) more likely to get hepatitis B compared to mothers with gravidity between1-6. Moreover, prevalence of hospital delivery was around one-third (36.5%) while almost another one-third was attended by TBAs. Finally, the study has found that the seroprevalence of HBsAg among pregnant women was 4.12%. Conclusion and Recommendation: The study found out that HBsAg prevalence among pregnant women in Mogadishu was 4.12%, significantly associated with age, economic status, gravidity, birth attendant and abortion. It is recommended that MoH and health professionals adopt universal screening of all pregnant women for HBsAg during each pregnancy, prophylaxis and routine vaccination of both mothers and infants and also management of Hepatitis B cases.
References
Maynard JE. Hepatitis B: global importance and need for control. Vaccine 1990; 8 Suppl: S18. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study.
Strickland G T, El-Kamary S. Viral Hepatitis. In: McGill, A; Ryan, E; Hill, D; Solomon, T, eds. Hunter's Tropical th Medicine and Emerging Infectious Diseases. 9 ed. New York: Saunders Elsevier; 2013: 290-305.
WHO (2017) World Health Organization, Global Hepatitis Report,
Lavanchy D. (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 2004;11:97–107. [PubMed].
Kiire C.F. (1996) The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut. 1996;38(Suppl. 2):S5–S12. [PMC free article] [PubMed]
Kramvis A., Kew M.C. (2007). Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol. Res. 2007;37(s1):S9–s19. [PubMed]
Ching-Lung L, Man-Fung Y. Chronic hepatitis B—new goals, new treatment. N Engl J Med 2008;359:2488–91.CrossRefPubMedWeb of ScienceGoogle Scholar.
Stevens CE, Toy PT, Tong MJ, et al. Hepatitis B virus transmission in the United States, prevention by passiveactive immunization. JAMA 1985; 253:1740–5.CrossRefPubMedWeb of Science Google Scholar. Beasley PR. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma, epidemiologic considerations. Hepatology 1982;(Suppl):21S–6S.Google Scholar Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003;(Suppl 1):S64–9.Google Scholar.
Cunninghan F, Leveno K, SL B, editors. Williams Obstetrics 22 ed: Mcgraw-hill, ; 2005.
Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol. 2005 Nov;43(5):771-5.
Okoth F, Mbuthia J, Gatheru Z, Murila F, Kanyingi F, Mugo F, et al. Seroprevalence of hepatitis B markers in pregnant women in Kenya. East Afr Med J. 2006
Akani CI, Ojule AC, Opurum HC, Ejilemele AA. Sero-prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Niger Postgrad Med J. 2005 Dec;12(4):266-70.
Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J. 2007;4:104.
WHO, 2013.http://www.who.int/mediacentre /factsheets/fs204/en/. Accessedon 5th January, 2013.
Higgins John W (2012).“Sense-Making as a method of practicing acritical pedagogy in the multi-cultural classroom”http:// communication. sbs. ohiostate. edu/ sense Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105(2):94–8.
World health statistics 2016: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2016 (http://apps.who.int/iris/ bitstream/10665/206498/1/9789241565264_eng. pdf?ua=1, accessed 10 March 2017).
Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976;294(14):746-9.
Keane E, Funk AL, Shimakawa Y. Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa. Aliment Pharmacol Ther. 2016, 44(10):1005-1017. Machaira M, Papaevangelou V, Vouloumanou EK, Tansarli GS, Falagas ME. Hepatitis B vaccine alone or with hepatitis B immunoglobulin in neonates of HBsAg+/HBeAg- mothers: a systematic review and meta-analysis. J Antimicrob Chemother. 2015;70:396-404.
LeeC,Gong Y, Brok J, Boxall EH,GluudC.Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers.Cochrane Database Syst Rev. 2006;(2):004790.DOI: 10.1002/14651858.CD004790.pub2.
Brown RS Jr, McMahon BJ, Lok AS et al. (2016) Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatology. 2016; 63:319 33.
WHO (2017) Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; March 2015
Lemoine M, Shimakawa Y, Njie R, Taal M, Ndow G, Chemin I et al. Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study. Lancet Glob Health. 2016;4 (8):e559–67. doi: 10.1016/S2214-109X(16)30130-9. Shankar H, Blanas D, Bichoupan K, et al. A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants. Clin Infect Dis. 2016; 62 Suppl 4:S289-97. Spradling PR, Xing J, Rupp LB, Moorman AC, Gordon SC, Teshale ET et al. Infrequent clinical assessment of chronic hepatitis B patients in United States general healthcare settings. Clin Infect Dis. 2016; 63:1205–8.
Kasper D, Braunwald E, Fauci A, editors. Harrison’s Principles of Internal Medicine, 16 ed: The Mc Graw-Hill; 2005. Kibassa CJ, Msengi AE. Determination of vertical transmission of hepatitis B virus in Dar es Salaam. Tanzania Medical Journal. 2004;19:21-5.
Menendez C, Sanchez-Tapias JM, Kahigwa E, Mshinda H, Costa J, Vidal J, et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol. 1999 Jul;58(3):215-20. Shao JF, Haukenes G, Yangi E, Vollset SE. Association of hepatitis B and human immunodeficiency virus infections in Tanzanian population groups. Eur J Clin Microbiol Infect Dis. 1993 Jan;12(1):62-4. Akani CI, Ojule AC, Opurum HC, Ejilemele AA. Sero-prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Niger Postgrad Med J. 2005 Dec;12(4):266-70.
Haukenes G SJ, Mbena E, Rustad S. Hepatitis B virus markers in the population of Das-es-salaam, Tanzania. J Infct 1987;15:183-8.
Matee MI, Lyamuya E. . Seroprevalence of human immunodeficiency, hepatitis B and C viruses and syphilis infections among blood donors at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health. 2008;6:21.
Nagu TJ, Bakari M, Matee MI. Hepatitis A, B and C viral co-infections among HIV infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health. 2008;8(416).
Chakravarti A, Rawat D, Jain M. A study on the perinatal transmission of the hepatitis B virus. Indian J Med Microbiol. 2005 Apr;23(2):128-30.
Alexander JM, Ramus R, Jackson G, Sercely B, Wendel GD, Jr. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol. 1999;7(6):283-6.
Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol. 2002 May;67(1):20-6.
Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol. 2002 Jun;99(6):1049-52.
Bwogi J, Braka F, Makumbi I, Mishra V, Bakamutumaho B, Nanyunja M, et al. Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. Afr Health Sci. 2009 Jun;9(2):98-108. Ferreira RC, Rodrigues FP, Teles SA, Lopes CL, Motta-Castro AR, Novais AC, et al. Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users. J Med Virol. 2009 Apr;81(4):602-9. Obi SN, Onah HE, Ezugwu FO. Risk factors for hepatitis B infection during pregnancy in a Nigerian obstetric population. J Obstet Gynaecol. 2006 Nov;26(8):770-2.
UNAIDS, UNAIDS report on the global AIDS epidemic 2010. UNAIDS/10.11E/JC1958E, November 2010. At http://www.unaids.org/globalreport/ documents/20101123_GlobalReport_full_en. Pdf.
NACP and NACP (2009). HIV/AIDS/STI Surveillance Report. July 2009.
Santiago-Munoz P, Roberts S, Sheffield J, McElwee B, Wendel GD, Jr. Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus. Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1270-3.
Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003; 39(Suppl.1): 64–9. Euler GL, Wooten KG, Baughman AL, Williams WW. Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission. Pediatrics 2003; 111: 1192–7.
Healy CM, Cafferkey MT, Butler KM, et al. Antenatal hepatitis B screening – is there a need for a national policy? Irish Med J 2001; 94: 111–2.
Wong S, Chan LY, Yu V, et al. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol 1999; 16: 485–8.
Tse KY, Lo LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case–control study. J Hepatol 2005; 43: 771–5.
Alexander JM, Ramus R, Jackson G, Sercely B, Wendel Jr G. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol 1999; 7: 283–6.
Soderstr¨om A, Norkrans G, Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003; 35: 814–9.
Lin HH, Chen PJ, Chen DS, et al. Postpartum subsidence of hepatitis B viral replication in HBeAg-positive carrier mothers. J Med Virol 1989; 29: 1–6.
Lin HH, Wu WY, Kao JH, et al. Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: correlation with viral characteristics. J Gastroenterol Hepatol 2006; 21: 605–9.
TerBorg MJ, Leemans WF, de Man RA, Janssen HLA. Exacerbation of chronic hepatitis B infection after delivery. J Vir Hepat 2008; 15: 37–41.
Yang Y-B, Li X-M, Shi Z-J, Ma L. Pregnant woman with fulminant hepatic failure caused by hepatitis B virus infection: a case report. World J Gastroenterol 2004; 10: 2305–6.
Santiago-Munoz P, Roberts S, Sheffield J, McElwee B, Wendel JGD. Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus. Am J Obstet Gynecol 2005; 193(Suppl. 1): 1270–3. Cobey FC, Salem RR. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 2004; 187: 181–91. de la Rosa MA, Nicol´as-P´erez D, Mu˜niz-Montes JR, et al. Evolution and management of a hepatocellular carcinoma during pregnancy. J Obstet Gynaecol Res 2006; 32: 437–9.
Gupta I, Ratho RK. Immunogenicity and safety of two schedules of hepatitis B vaccination during pregnancy. J Obstet Gynaecol Res 2003; 29: 84–6.
Levy M, Koren G. Hepatitis B vaccine in pregnancy: maternal and fetal safety. Am J Perinatol 1991; 8: 227–32. Xu DZ, Yan YP,Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case– control study. J Med Virol 2002; 67: 20–6.
Li X-M, Shi M-F, Yang Y-B, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004; 10: 3215–7.
Bai H, Zhang L, Ma L, et al. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intrauterine transmission mechanism. World J Gastroenterol 2007; 13: 3625–30.
Lin HH, Lee TY, Chen DS, et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987; 111: 877–81. Zhu QR, Ge YL, Gu SQ, et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J 2005; 118: 1604–9.
Yu H, Zhu QR, Gu SQ, et al. Relationship between IFN-gamma gene polymorphism and susceptibility to intrauterine HBV infection. World J Gastroenterol 2006; 12: 2928–31.
Lee S-D, Tsai K-S, Wu T-C, et al. Role of caesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet 1988; 2: 833–4.
Lee C, Gong Y, Brok J, Boxall EH, Gluud C. (2006) Effect of hepatitis B immunization in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and metaanalysis. BMJ 2006; 332: 328–36.
del Canho R, Grosheide PM, Mazel JA, et al (1997). Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982–1992: protective efficacy and long-term immunogenicity. Vaccine 1997; 15: 1624–30.
Xiao XM, Li AZ, Chen X, Zhu YK, Miao J. (2007). Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynecol Obstet 2007; 96: 167–70.
Yuan J, Lin J, Xu A, et al (2006). Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepatol 2006; 13: 597–604.
Xu Q, Xiao L, Lu X-B, Zhang Y-X, Cai X. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol 2006; 12: 3434–7. Xu WM, Cui YT, Wang L, et al. Efficacy and safety of lamivudine in late pregnancy for the prevention of mother–child transmission of hepatitis B: a multicentre, randomized, double-blind, placebo-controlled study [abstract]. Hepatology 2004; 40: 272A.
Wong VC, Lee AKY, Ip HMH (1980). Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. Br J Obstet Gynaecol 1980; 87: 958–65.
Lee AK, Ip HM, Wong VC. Mechanisms of maternal–fetal transmission of hepatitis B virus. J Infect Dis 1978; 138: 668–71.
Beasley RP, Stevens CE, Shiao IS, Meng HC, et al. (1975) Evidence against breastfeeding as a mechanism for vertical transmission of hepatitis B. Lancet 1975; 2: 740–1.
Jacqueline Asundula Malungu Ngaira, James Kimotho, Isaac Mirigi, Saida Osman, Zipporah Ng’ang’a, Raphael Lwembe,and Missiani Ochwoto(2016). Prevalence, awareness and risk factors associated with Hepatitis B infection among pregnant women attending the antenatal clinic at Mbagathi District Hospital in Nairobi, Kenya.
Abdi Umare, Berhanu Seyoum, Tesfaye Gobena, Tamirat Haile Mariyam (2016) Hepatitis B Virus Infections and Associated Factors among Pregnant Women Attending Antenatal Care Clinic at Deder Hospital, Eastern Ethiopia
Mahamat A LD, Vaz T, Demar M, Nacher M, Djossou F. (2010) High prevalence of HBsAg during pregnancy in Asian communities at Cayenne Hospital, French Guiana. Am J Trop Med Hyg Sep;83(3):711-3.
Rabiu KA AO, Adewunmi AA, Omololu OM, Ojo (2010). Risk factors for hepatitis B virus infection among pregnant women in Lagos, Nigeria. Acta Obstet Gynecol Scand 2010 Aug;89(8):1024-8.
El-Magrahe H FA, El-Figih K, El-Urshfany S, Ghenghesh KS (2010). Maternal and neonatal seroprevalence of Hepatitis B surface antigen (HBsAg) in Tripoli, Libya. J Infect Dev Ctries. 2010 Mar 29;4(3):168-70.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Archives of Business Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
